Feedback / Questions
ARTS-023 - Avenzo Therap
AVZO-021 - Avenzo Therap
https://www.businesswire.com/news/home/20250605783144/en/Avenzo-Therapeutics-Initiates-Phase-12-Clinical-Study-of-AVZO-023-a-Potential-Best-in-Class-Novel-CDK4-Selective-Inhibitor
Jun 5, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next